Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Aspirin

Research Leaders

5 sponsors active, led by Kuopio University Hospital

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT00683202Not ApplicableCompleted

Low-Dose Aspirin in in Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) Treatments

NCT00573118Unknown

Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity

Showing all 2 trials

Research Network

Common Treatments

  • Aspirin1

Active Sponsors

  • Kuopio University Hospital1
  • Tampere University1
  • Bayer1
  • University of Oulu1
  • Tel-Aviv Sourasky Medical Center1

Top Investigators

Related Conditions

  • Preeclampsia2
  • Placental Abruption1
  • Intrauterine Fetal Death1
  • Miscarriage Less Than 12 Gestational Weeks1
  • Extrauterine Pregnancy1

Activity Timeline